Member Announcements
June 18, 2013University of Victoria
June 18, 2013
iCo Therapeutics Inc.
June 17, 2013
BIOTECanada
June 17, 2013
Gowlings
June 14, 2013
Canada’s Research-Based Pharmaceutical Companies (Rx&D)
June 14, 2013
QLT Inc.
June 13, 2013
RxnD
June 13, 2013
Centre for Drug Research and Development
June 13, 2013
Qu Biologics Inc.
June 13, 2013
BC Centre for Excellence in HIV/AIDS
June 13, 2013
LED Medical Diagnostics
June 12, 2013
EnWave Corporation
June 12, 2013
Celgene Corporation
June 12, 2013
Centre for Drug Research and Development
June 12, 2013
University of British Columbia
June 12, 2013
University of British Columbia
June 12, 2013
Pfizer Canada
June 12, 2013
Functional Technologies Corp.
June 11, 2013
Centre for Drug Research and Development
June 11, 2013
Rx&D
June 11, 2013
Qu Biologics Inc.
June 11, 2013
inVentiv Health Inc.
June 10, 2013
Xenon Pharmaceuticals Inc.
June 10, 2013
Merck Canada Inc.
June 10, 2013
Phyton Biotech
June 10, 2013
Covance Inc.
June 10, 2013
Simon Fraser University
June 9, 2013
TRIUMF
June 7, 2013
Verisante Technology, Inc.
June 6, 2013
Michael Smith Foundation for Health Research
June 6, 2013
Rick Hansen Institute
June 6, 2013
The Centre for Drug Research and Development
June 6, 2013
Ondine Biomedical Inc.
June 5, 2013
Del Mar Pharmaceuticals
June 5, 2013
MPI Research
June 5, 2013
StarFish Medical
June 4, 2013
University of British Columbia
June 4, 2013
Verisante Technology, Inc.
June 3, 2013
BC Cancer Foundation
June 3, 2013
Genome British Columbia
June 3, 2013
Boehringer Ingelheim (Canada) Ltd.
June 3, 2013
University of British Columbia
June 1, 2013
Del Mar Pharmaceuticals
May 31, 2013
Maxxam Analytics
May 31, 2013
OncoGenex Pharmaceuticals, Inc.
May 31, 2013
Michael Smith Foundation for Health Research
May 30, 2013
University of Northern British Columbia
May 30, 2013
Qu Biologics Inc.
May 29, 2013
Abbott Laboratories, Limited.
May 29, 2013
RepliCel Life Sciences Inc.
May 29, 2013
iCo Therapeutics
May 29, 2013
Sirona Biochem Corp.
May 29, 2013
Sirona Biochem Corp.
May 28, 2013
Neovasc Inc.
May 28, 2013
MPI Research
May 28, 2013
BC Institute of Technology
May 28, 2013
Verisante Technology, Inc.
May 28, 2013
Michael Smith Foundation for Health Research
May 24, 2013
University of Northern British Columbia
May 24, 2013
Wax-it Histology Services Inc.
May 24, 2013
University of British Columbia
May 24, 2013
GlaxoSmithKline Inc.
May 24, 2013
Discovery Parks
May 24, 2013
iCo Therapeutics Announces Director Election Results from its Annual General Meeting of Shareholders
iCo Therapeutics Inc.
May 24, 2013
University of British Columbia
May 24, 2013
ICORD
May 24, 2013
MPI Research
May 23, 2013
Celgene
May 23, 2013
Rx&D
May 23, 2013
University of British Columbia
May 23, 2013
Neovasc Inc.
May 23, 2013
OncoGenex Pharmaceuticals, Inc.
May 23, 2013
RepliCel Life Sciences Inc.
May 22, 2013
OncoGenex Pharmaceuticals, Inc.
May 22, 2013
University of British Columbia
May 22, 2013
Michael Smith Foundation for Health Research
May 22, 2013
Michael Smith Foundation for Health Research
May 21, 2013
Neovasc Inc.
May 21, 2013
Celator Pharmaceuticals, Inc.
May 21, 2013
RepliCel Life Sciences Inc.
May 21, 2013
Novadaq® Technologies Inc.
May 21, 2013
Covance Inc.
May 21, 2013
Simon Fraser University
May 20, 2013
Cardiome Pharma Corp.
May 17, 2013
University of Northern British Columbia
May 17, 2013
Novadaq® Technologies Inc.
May 17, 2013
UCB
May 17, 2013
Michael Smith Foundation for Health Research
May 17, 2013
Tekmira Pharmaceuticals Corporation
May 17, 2013
UCB
May 16, 2013
UCB
May 16, 2013
Optum
May 16, 2013
Boehringer Ingelheim (Canada) Ltd.
May 15, 2013
Tekmira Pharmaceuticals Corporation
May 15, 2013
BC Cancer Foundation
May 14, 2013
Canada's Research-Based Pharmaceutical Companies
May 14, 2013
StarFish Medical
May 14, 2013
Wavefront
May 14, 2013
University of British Columbia
May 14, 2013
University of British Columbia
May 13, 2013
Sirona Biochem Corp.
May 13, 2013
Sorin Group
May 13, 2013
Sorin Group
May 13, 2013
Neovasc Inc.
May 13, 2013
Genome British Columbia
May 13, 2013
Covance Inc.
May 13, 2013
Cardiome Pharma Corp.
May 13, 2013
Response Biomedical Corp.
May 10, 2013
iCo Therapeutics Inc.
May 10, 2013
GlaxoSmithKline Inc.
May 10, 2013
Cardiome Pharma Corp.
May 10, 2013
Merck Canada Inc.
May 10, 2013
TRIUMF
May 10, 2013
iCo Therapeutics Inc.
May 10, 2013
Verisante Technology, Inc.
May 10, 2013
Centre for Drug Research and Development
May 10, 2013
StarFish Medical
May 9, 2013
Tekmira Pharmaceuticals Corporation
May 9, 2013
Functional Technologies Corp.
May 9, 2013
Wavefront
May 9, 2013
Cardiome Pharma Corp.
May 9, 2013
UCB Canada Inc.
May 8, 2013
EnWave Corporation
May 8, 2013
Tekmira Pharmaceuticals Corporation
May 8, 2013
GenomeDx Biosciences
May 8, 2013
University of British Columbia
May 8, 2013
Michael Smith Foundation for Health Research
May 7, 2013
Wavefront
May 7, 2013
Novadaq® Technologies Inc.
May 7, 2013
Response Biomedical Corp.
May 6, 2013
University of British Columbia
May 6, 2013
Sorin Group
May 6, 2013
Covance Inc.
May 6, 2013
Sirona Biochem Corp.
May 3, 2013
TRIUMF
May 3, 2013
RepliCel Life Sciences Inc.
May 3, 2013
University of British Columbia
May 3, 2013
Sirona Biochem Corp.
May 2, 2013
Cardiome Pharma Corp.
May 2, 2013
Covance Inc.
May 2, 2013
Simon Fraser University
May 2, 2013
Discovery Parks
May 2, 2013
QLT Inc.
May 2, 2013
Michael Smith Foundation for Health Research
May 2, 2013
OncoGenex Pharmaceuticals, Inc.
May 1, 2013
OncoGenex Pharmaceuticals, Inc.
May 1, 2013
BC Cancer Foundation
May 1, 2013
Simon Fraser University
May 1, 2013
Novadaq® Technologies Inc.
May 1, 2013
Optum
April 30, 2013
Sorin Group
April 30, 2013
inVentiv Health, Inc.
April 30, 2013
OncoGenex Pharmaceuticals, Inc.
April 30, 2013
RepliCel Life Sciences Inc.
April 30, 2013
STEMCELL Technologies Inc.
April 30, 2013
Novadaq® Technologies Inc.
April 30, 2013
University of British Columbia
April 30, 2013
Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing
Celator Pharmaceuticals, Inc.
April 30, 2013
TRIUMF
April 29, 2013
Novadaq® Technologies Inc.
April 29, 2013
Sorin Group
April 29, 2013
Sorin Group
April 29, 2013
Celgene Corporation
April 29, 2013
Biolux Research Ltd.
April 29, 2013
University of British Columbia
April 29, 2013
Simon Fraser University
April 29, 2013
Neovasc Inc.
April 29, 2013
MPI Research
April 29, 2013
Allon Therapeutics Inc.
April 28, 2013
OncoGenex Pharmaceuticals, Inc.
April 26, 2013
Verisante Technology, Inc.
April 25, 2013
Celgene Corporation
April 25, 2013
Functional Technologies Corp.
April 25, 2013
Genome British Columbia
April 25, 2013
Cardiome Pharma Corp.
April 25, 2013
University of Victoria
April 25, 2013
Functional Technologies Corp.
April 25, 2013
OncoGenex Pharmaceuticals, Inc.
April 24, 2013
Christensen O'Connor Johnson Kindness PLLC
April 24, 2013
StarFish Medical
April 24, 2013
Wax-it Histology Services
April 24, 2013
viDA Therapeutics Inc.
April 24, 2013
Arazy Group
April 24, 2013
Michael Smith Foundation for Health Research
April 23, 2013
Xenon Pharmaceuticals Inc.
April 23, 2013
University of British Columbia
April 23, 2013
Perceptronix Medical Inc
April 23, 2013
Aquinox Pharmaceuticals Inc.
April 23, 2013
OncoGenex Pharmaceuticals, Inc.
April 23, 2013
Boehringer Ingelheim (Canada) Ltd.
April 22, 2013
Xenon Pharmaceuticals Inc.
April 22, 2013
Novadaq® Technologies Inc.
April 22, 2013
Genome British Columbia
April 22, 2013
Merck Canada
April 22, 2013
Michael Smith Foundation for Health Research
April 22, 2013
Michael Smith Foundation for Health Research
April 19, 2013
Novadaq® Technologies Inc.
April 19, 2013
ICORD
April 18, 2013
RepliCel Life Sciences Inc.
April 18, 2013
Merck Canada Inc.
April 18, 2013
Genome British Columbia
April 17, 2013
Xenon Pharmaceuticals Inc.
April 17, 2013
MPI Research
April 16, 2013
Zymeworks Inc.
April 16, 2013
Christensen O'Connor Johnson Kindness PLLC
April 16, 2013
Verisante Technology, Inc.
April 16, 2013
University of British Columbia
April 16, 2013
EnWave Corporation
April 16, 2013
StarFish Medical
April 16, 2013
Covance Inc.
April 15, 2013
QLT Inc.
April 15, 2013
Genome British Columbia
April 15, 2013
BC Cancer Foundation
April 12, 2013
Cardiome Pharma Corp.
April 12, 2013
Rick Hansen Foundation Grants $20M Towards Research for Cures for Paralysis After Spinal Cord Injury
Rick Hansen Institute
April 12, 2013
Arazy Group
April 12, 2013
BC Cancer Foundation
April 12, 2013
Michael Smith Foundation for Health Research
April 11, 2013
OncoGenex Pharmaceuticals, Inc.
April 11, 2013
Simon Fraser University
April 11, 2013
Simon Fraser University
April 11, 2013
University of British Columbia
April 10, 2013
Sirona Biochem Corp.
April 10, 2013
Tekmira Pharmaceuticals Corporation
April 10, 2013
StarFish Medical
April 10, 2013
University of British Columbia
April 10, 2013
University of British Columbia
April 10, 2013
The Centre for Drug Research and Development
April 10, 2013
BC Cancer Agency
April 10, 2013
RepliCel Life Sciences Inc.
April 9, 2013
University of British Columbia
April 9, 2013
Sorin Group
April 9, 2013
Neurodyn Inc.
April 8, 2013
University of British Columbia
April 8, 2013
Xenon Pharmaceuticals Inc.
April 8, 2013
Michael Smith Foundation for Health Research
April 5, 2013
Inception Sciences Canada
April 5, 2013
University of British Columbia
April 5, 2013
Michael Smith Foundation for Health Research
April 4, 2013
The University of British Columbia Appoints Dr. Michael Coughtrie as Dean of Pharmaceutical Sciences
University of British Columbia
April 4, 2013
Cardiome Pharma Corp.
April 4, 2013
University of British Columbia
April 4, 2013
ICORD
April 3, 2013
Genome British Columbia
April 3, 2013
Aquinox Pharmaceuticals Inc.
April 3, 2013
Covance Inc.
April 3, 2013
Celgene Corporation
April 2, 2013
Solegear Bioplastics Inc.
April 2, 2013
StarFish Medical
April 2, 2013
Farris, Vaughan, Wills & Murphy LLP
April 2, 2013
Centre for Drug Research and Development
April 2, 2013
ICORD
April 2, 2013
University of British Columbia
April 2, 2013
Cardiome Pharma Corp.
March 28, 2013
Genome BC
March 28, 2013
OncoGenex Pharmaceuticals, Inc.
March 28, 2013
StarFish Medical
March 28, 2013
Cardiome Pharma Corp.
March 28, 2013
CDRD President and CEO to speak at the 9th Annual PHCRI Research Day – April 16, 2013, Vancouver, BC
Centre for Drug Research and Development
March 28, 2013
Lungpacer Medical Inc.
March 28, 2013
Centre for Drug Research and Development
March 26, 2013
StarFish Medical
March 26, 2013
University of British Columbia
March 26, 2013
Cardiome Pharma Corp.
March 26, 2013
University of British Columbia
March 26, 2013
Genome British Columbia
March 25, 2013
Michael Smith Foundation for Health Research
March 24, 2013
Vancouver Board of Trade
March 22, 2013
Arazy Group
March 22, 2013
LEO Pharma A/S
March 22, 2013
Canada’s Research-Based Pharmaceutical Companies (Rx&D)
March 22, 2013
Functional Technologies Corp.
March 21, 2013
University of British Columbia
March 21, 2013
Michael Smith Foundation for Health Research
March 21, 2013
STEMCELL Technologies Inc
March 20, 2013
Sorin Group
March 20, 2013
Biolux Research Ltd.
March 20, 2013
Farris, Vaughan, Wills & Murphy LLP
March 20, 2013
Verisante Technology, Inc.
March 20, 2013
University of British Columbia
March 20, 2013
Sirona Biochem Corp.
March 20, 2013
LEO Pharma A/S
March 20, 2013
University of British Columbia
March 19, 2013
LEO Pharma
March 19, 2013
Cardiome Pharma Corp.
March 15, 2013
Novadaq® Technologies Inc.
March 15, 2013
Cardiome Pharma Corp.
March 15, 2013
University of British Columbia
March 15, 2013
ICORD
March 15, 2013
University of British Columbia
March 15, 2013
Sorin Group
March 15, 2013
LEO Pharma
March 14, 2013
Sirona Biochem Corp.
March 14, 2013
Sorin Group
March 14, 2013
University of British Columbia
March 14, 2013
Arazy Group
March 13, 2013
Genzyme
March 13, 2013
Michael Smith Foundation for Health Research
March 13, 2013
inVentiv Health, Inc.,
March 12, 2013
Rick Hansen Institute
March 12, 2013
Cardiome Pharma Corp.
March 12, 2013
Rocket Builders
March 12, 2013
University of British Columbia
March 12, 2013
University of Northern British Columbia
March 12, 2013
Network Immunology Inc.
March 11, 2013
Genome British Columbia
March 11, 2013
Sirona Biochem Corp.
March 11, 2013
Centre for Drug Research and Development
March 11, 2013
Arazy Group
March 11, 2013
Response Biomedical Corp.
March 11, 2013
Neurodyn Inc.
March 8, 2013
Michael Smith Foundation for Health Research
March 7, 2013
Qu Biologics
March 7, 2013
SPUD Adds Extra Incentive for Bust a Move Participants to Make Their Move for Breast Cancer Research
BC Cancer Foundation
March 7, 2013
OncoGenex Pharmaceuticals, Inc.
March 6, 2013
Covance Inc.
March 6, 2013
Response Biomedical Corp.
March 6, 2013
University of British Columbia
March 6, 2013
University of British Columbia
March 6, 2013
Sirona Biochem Corp.
March 6, 2013
Aurora Biomed
March 5, 2013
BC Cancer Foundation
March 5, 2013
Genome British Columbia
March 5, 2013
ICORD
March 5, 2013
Michael Smith Foundation for Health Research
March 5, 2013
Zymeworks Inc.
March 4, 2013
Cardiome Pharma Corp.
March 4, 2013
Rick Hansen Institute
March 1, 2013
University of British Columbia
February 28, 2013
Sorin Group
February 28, 2013
Simon Fraser University
February 28, 2013
Neovasc Inc.
February 28, 2013
OncoGenex Pharmaceuticals, Inc.
February 28, 2013
Michael Smith Foundation for Health Research
February 28, 2013
TRIUMF
February 28, 2013
University of British Columbia
February 27, 2013
Verisante Technology, Inc.
February 27, 2013
University of British Columbia
February 27, 2013
EnWave Corporation
February 27, 2013
Genzyme
February 26, 2013
Qu Biologics Inc.
February 26, 2013
Response Biomedical Corp.
February 26, 2013
Genome British Columbia
February 26, 2013
Covance Inc.
February 26, 2013
Wax-it Histology Services
February 25, 2013
Sex & Drugs & Reproductive Health: Celebrate Research 2013 at UBC Faculty of Pharmaceutical Sciences
University of British Columbia
February 22, 2013
Sirona Biochem Corp.
February 21, 2013
Genome BC
February 21, 2013
Centre for Drug Research and Development
February 21, 2013
Centre for Drug Research and Development
February 21, 2013
Michael Smith Foundation for Health Research
February 21, 2013
University of British Columbia
February 21, 2013
University of British Columbia
February 20, 2013
Verisante Technology, Inc.
February 20, 2013
Michael Smith Foundation for Health Research
February 20, 2013
CBRE Limited
February 20, 2013
University of British Columbia
February 20, 2013
University of British Columbia
February 20, 2013
Arazy Group
February 19, 2013
University of British Columbia
February 19, 2013
Sorin Group
February 19, 2013
EnWave Corporation
February 19, 2013
RepliCel
February 19, 2013
University of British Columbia
February 18, 2013
Coastal Genomics Inc.
February 18, 2013
StarFish Medical
February 17, 2013
University of British Columbia
February 15, 2013
Rick Hansen Institute
February 14, 2013
EnWave Corporation
February 14, 2013
iCo Therapeutics Inc.
February 13, 2013
Verisante Technology, Inc.
February 13, 2013
Xenon Pharmaceuticals Inc.
February 13, 2013
CDRD
February 13, 2013
University of British Columbia
February 12, 2013
Arazy Group
February 12, 2013
University of British Columbia
February 12, 2013
Sirona Biochem Corp.
February 12, 2013
OncoGenex Pharmaceuticals, Inc.
February 12, 2013
Covance Inc.
February 12, 2013
Tekmira Pharmaceuticals Corporation
February 12, 2013
University of British Columbia
February 12, 2013
University of British Columbia
February 12, 2013
Vancouver Board of Trade
February 12, 2013
Neurodyn Inc.
February 8, 2013
Verisante
February 8, 2013
StarFish Medical
February 8, 2013
RepliCel Life Sciences Inc.
February 7, 2013
Novadaq Technologies Inc.
February 7, 2013
Sorin Group Canada Inc.
February 7, 2013
Superna Life Sciences
February 7, 2013
Rick Hansen Institute
February 7, 2013
Wax-it Histology Services
February 6, 2013
Tekmira Pharmaceuticals Corporation
February 6, 2013
Michael Smith Foundation for Health Research
February 6, 2013
Centre for Drug Research and Development
February 6, 2013
Gowling Lafleur Henderson LLP
February 6, 2013
University of British Columbia
February 6, 2013
ICORD
February 6, 2013
Vancouver Prostate Cancer
February 5, 2013
Allon Therapeutics Inc.
February 5, 2013
inVentiv Health, Inc.
February 5, 2013
OncoGenex Pharmaceuticals, Inc.
February 5, 2013
HP Adds Reseller for Mobile Testing, Monitoring Suite; Frances Newbigin Comments (via Executive Biz)
Wavefront
February 5, 2013
iCo Therapeutics Inc.
February 5, 2013
Insception Lifebank
February 4, 2013
Biolux Research Ltd.
February 4, 2013
University of British Columbia
January 22, 2013
Sirona Biochem Corp.
January 22, 2013
Solegear Bioplastics Inc.
January 22, 2013
iCo Therapeutics Inc.
January 21, 2013
Centre for Drug Research and Development
January 21, 2013
StarFish Medical
January 21, 2013
University of British Columbia
January 21, 2013
University of Northern British Columbia
January 18, 2013
Simon Fraser University
January 18, 2013
Sirona Biochem Corp.
January 17, 2013
MPI Research
January 17, 2013
Verisante Technology, Inc.
January 17, 2013
Simon Fraser University
January 16, 2013
University of British Columbia
January 16, 2013
Christensen O'Connor Johnson Kindness PLLC
January 15, 2013
BC Cancer Foundation
January 15, 2013
The Centre for Drug Research and Development
January 15, 2013
Merck
January 14, 2013
University of British Columbia
January 14, 2013
BC Clinical Research Infrastructure Network
January 10, 2013
Verisante Technology, Inc.
January 9, 2013
Response Biomedical Corporation
January 8, 2013
StarFish Biomedical
January 8, 2013
Enwave Corporation
January 7, 2013
Sirona Biochem Corp.
January 7, 2013
Vancouver Economic Commission
January 7, 2013
Celator Pharmaceuticals
January 4, 2013
StarFish Medical
January 4, 2013
Vancouver Economic Commission
January 3, 2013
iCo Therapeutics Inc.
January 3, 2013
PROOF Centre of Excellence
January 3, 2013
Vancouver Economic Commission
January 2, 2013
Response Biomedical Corp.
